Evidence map›Paper›PMID 32819917›Full record

ArticleBMJ global health2020

Impact of the societal response to COVID-19 on access to healthcare for non-COVID-19 health issues in slum communities of Bangladesh, Kenya, Nigeria and Pakistan: results of pre-COVID and COVID-19 lockdown stakeholder engagements.

Syed A K Shifat Ahmed, Motunrayo Ajisola, Kehkashan Azeem, Pauline Bakibinga, Yen-Fu Chen, Nazratun Nayeem Choudhury, Olufunke Fayehun, Frances Griffiths, Bronwyn Harris, Peter Kibe and 32 more

Open access · goldAbstract read
In one paragraph

Article in BMJ global health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 173 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
173citing papers in PubMed, 2 pooled it
10.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

173 citing papers in PubMed, 2 syntheses or guidelines pooled it, 383 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Spatiotemporal distribution of leptospirosis in the Espirito Santo State, Brazil.Revista do Instituto de Medicina Tropical de Sao Paulo · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article

113 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors at 9 institutions in 6 countries.

Syed A K Shifat AhmedCentre for Health, Population and Development, Independent University Bangladesh, Dhaka, Bangladesh.ORCID 0000-0001-8166-7971
Motunrayo AjisolaNational Institute for Health Research Project, University of Ibadan, Ibadan, Oyo State, Nigeria.ORCID 0000-0002-1704-0944
Kehkashan AzeemCommunity Health Sciences Department, Aga Khan University, Karachi, Pakistan.
Pauline BakibingaAfrican Population and Health Research Center, Nairobi, Kenya.ORCID 0000-0001-7097-5450
Yen-Fu ChenDivision of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK.ORCID 0000-0002-9446-2761
Nazratun Nayeem ChoudhuryCentre for Health, Population and Development, Independent University Bangladesh, Dhaka, Bangladesh.
Olufunke FayehunDepartment of Sociology, Faculty of Social Sciences, University of Ibadan, Ibadan, Oyo State, Nigeria.
Frances GriffithsDivision of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK f.e.griffiths@warwick.ac.uk.ORCID 0000-0002-4173-1438
Bronwyn HarrisDivision of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK.ORCID 0000-0003-4695-008X
Peter KibeAfrican Population and Health Research Center, Nairobi, Kenya.ORCID 0000-0002-9027-9054
Richard J LilfordInstitute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Akinyinka OmigbodunDepartment of Obstetrics and Gynaecology, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Oyo State, Nigeria.ORCID 0000-0002-6377-9299
Narjis RizviCommunity Health Sciences Department, Aga Khan University, Karachi, Pakistan.
Jo SartoriInstitute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Simon SmithDivision of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK.
Samuel I WatsonDivision of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK.
Ria WilsonDivision of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK.
Godwin YeboahInstitute for Global Sustainable Development, University of Warwick, Coventry, UK.ORCID 0000-0003-4618-3175
Navneet AujlaDivision of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK.ORCID 0000-0001-6091-446X
Syed Iqbal AzamCommunity Health Sciences Department, Aga Khan University, Karachi, Pakistan.ORCID 0000-0003-0766-4064
Peter J DiggleLancaster Medical School, Lancaster University, Lancaster, UK.
Paramjit GillDivision of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK.ORCID 0000-0001-8756-6813
Romaina IqbalCommunity Health Sciences Department, Aga Khan University, Karachi, Pakistan.
Caroline KabariaAfrican Population and Health Research Center, Nairobi, Kenya.ORCID 0000-0002-5641-5243
Lyagamula KisiaAfrican Population and Health Research Center, Nairobi, Kenya.
Catherine KyobutungiAfrican Population and Health Research Center, Nairobi, Kenya.ORCID 0000-0002-5344-5631
Jason J MadanWarwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.
Blessing MberuAfrican Population and Health Research Center, Nairobi, Kenya.
Shukri F MohamedAfrican Population and Health Research Center, Nairobi, Kenya.ORCID 0000-0002-8693-1943
Ahsana NazishCommunity Health Sciences Department, Aga Khan University, Karachi, Pakistan.
Oladoyin OdubanjoNigerian Academy of Science, Lagos, Nigeria.
Mary E OsuhDepartment of Periodontology and Community Dentistry, Faculty of Dentistry, College of Medicine, University of Ibadan, Ibadan, Oyo State, Nigeria.ORCID 0000-0003-2367-6487
Eme OwoajeDepartment of Community Medicine, Faculty of Public Health, College of Medicine, University of Ibadan, Ibadan, Oyo State, Nigeria.
Oyinlola OyebodeDivision of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK.ORCID 0000-0003-0925-9839
Joao Porto de AlbuquerqueInstitute for Global Sustainable Development, University of Warwick, Coventry, UK.ORCID 0000-0002-3160-3168
Omar RahmanUniversity of Liberal Arts Bangladesh, Dhaka, Bangladesh.ORCID 0000-0002-0606-2507
Komal TabaniCommunity Health Sciences Department, Aga Khan University, Karachi, Pakistan.
Olalekan John TaiwoDepartment of Geography, Faculty of Social Sciences, University of Ibadan, Ibadan, Oyo State, Nigeria.
Grant TregonningInstitute for Global Sustainable Development, University of Warwick, Coventry, UK.ORCID 0000-0001-9649-7653
Olalekan A UthmanDivision of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK.ORCID 0000-0002-8567-3081
Rita YusufCentre for Health, Population and Development, Independent University Bangladesh, Dhaka, Bangladesh.ORCID 0000-0002-0151-9571
Improving Health in Slums Collaborative
University of Warwick · GBAfrican Population and Health Research Center · KEAga Khan University · PKUniversity of Ibadan · NGIndependent University · BDUniversity of Birmingham · GBLancaster University · GBUniversity of Liberal Arts Bangladesh · BDUniversity of the Witwatersrand · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionWith COVID-19, there is urgency for policymakers to understand and respond to the health needs of slum communities. Lockdowns for pandemic control have health, social and economic consequences. We consider access to healthcare before and during COVID-19 with those working and living in slum communities.

methodsIn seven slums in Bangladesh, Kenya, Nigeria and Pakistan, we explored stakeholder perspectives and experiences of healthcare access for non-COVID-19 conditions in two periods: pre-COVID-19 and during COVID-19 lockdowns.

resultsBetween March 2018 and May 2020, we engaged with 860 community leaders, residents, health workers and local authority representatives. Perceived common illnesses in all sites included respiratory, gastric, waterborne and mosquitoborne illnesses and hypertension. Pre-COVID, stakeholders described various preventive, diagnostic and treatment services, including well-used antenatal and immunisation programmes and some screening for hypertension, tuberculosis, HIV and vectorborne disease. In all sites, pharmacists and patent medicine vendors were key providers of treatment and advice for minor illnesses. Mental health services and those addressing gender-based violence were perceived to be limited or unavailable. With COVID-19, a reduction in access to healthcare services was reported in all sites, including preventive services. Cost of healthcare increased while household income reduced. Residents had difficulty reaching healthcare facilities. Fear of being diagnosed with COVID-19 discouraged healthcare seeking. Alleviators included provision of healthcare by phone, pharmacists/drug vendors extending credit and residents receiving philanthropic or government support; these were inconsistent and inadequate.

conclusionSlum residents' ability to seek healthcare for non-COVID-19 conditions has been reduced during lockdowns. To encourage healthcare seeking, clear communication is needed about what is available and whether infection control is in place. Policymakers need to ensure that costs do not escalate and unfairly disadvantage slum communities. Remote consulting to reduce face-to-face contact and provision of mental health and gender-based violence services should be considered.

Indexed as

Coronavirus InfectionsHealth Services AccessibilityPandemicsPneumonia, ViralPoverty AreasAfrica South of the SaharaAsia, WesternBetacoronavirusCOVID-19HumansPublic HealthSARS-CoV-2Stakeholder Participationdiseasedisorderhealth policyhealth systemsor injuryother infectionpublic healthqualitative study

Identifiers

PMID32819917
PMCPMC7443197
OpenAlexW3062442779

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.